PubMed · 1997 · 15 citations · 0 references
MedicineHematologyOncologyChemotherapyHematologic OncologyHematopathologyNail Disorder PharmacotherapyNail DisordersPigment ChangesPigment DepositionPigmentary DisordersPigmented Oral LesionsAcute Leukemia ChemotherapyDrug-induced Nail DisordersDrug-induced Pigmentary ChangesNail DiscolorationNail Pigmentation DisordersNail ToxicityOral Pigmentation ChangesPigmentation
A case of acute myelocytic leukemia of the FAB-M2 subtype in a patient who experienced pigmentary nail changes in conjunction with idarubicin therapy is presented. Although doxorubicin and daunorubicin have been reported to cause nail pigmentation changes, this is the first case report to describe these changes with idarubicin.